15 June 2016: Articles
A Patient Presenting with Tuberculous Encephalopathy and Human Immunodeficiency Virus Infection
Challenging differential diagnosis, Management of emergency care, Rare disease
Jason Li BCDEF , Suraiya Afroz BCEF , Eric French BEF , Anuj Mehta BDEDOI: 10.12659/AJCR.897745
Am J Case Rep 2016; 17:406-411
Abstract
BACKGROUND: In the USA, Mycobacterium tuberculosis infection is more likely to be found in foreign-born individuals, and those co-infected with human immunodeficiency virus (HIV) are more likely to have tuberculous meningitis. The literature is lacking in details about the clinical workup of patients presenting with tuberculous meningitis with encephalopathic features who are co-infected with HIV. This report demonstrates a clinical approach to diagnosis and management of tuberculous meningitis.
CASE REPORT: A 33-year-old Ecuadorean man presented with altered consciousness and constitutional symptoms. During the workup he was found to have tuberculous meningitis with encephalopathic features and concurrent HIV infection. Early evidence for tuberculosis meningitis included lymphocytic pleocytosis and a positive interferon gamma release assay. A confirmatory diagnosis of systemic infection was made based on lymph node biopsy. Imaging studies of the neck showed scrofula and adenopathy, and brain imaging showed infarctions, exudates, and communicating hydrocephalus. Treatment was started for tuberculous meningitis, while anti-retroviral therapy for HIV was started 5 days later in combination with prednisone, given the risk of immune reconstitution inflammatory syndrome (IRIS).
CONCLUSIONS: A clinical picture consistent with tuberculous meningitis includes constitutional symptoms, foreign birth, lymphocytic pleocytosis, specific radiographic findings, and immunodeficiency. Workup for tuberculous meningitis should include MRI, HIV screening, and cerebral spinal fluid analysis. It is essential to treat co-infection with HIV and to assess for IRIS.
Keywords: AIDS-Related Opportunistic Infections - diagnosis, HIV Infections - complications, Tuberculosis, Meningeal - diagnosis
Background
According to the World Health Organization, approximately one-third of the world’s population is infected with
Case Report
A 33-year-old Ecuadorean man presented to the Emergency Department with obtundation, diaphoresis, and aphasia for the past 4 hours. A history was obtained from his sister, who stated that the patient had been experiencing symptoms of headache, weakness, myalgias, and weight loss over the past 3 weeks. He had emigrated from Ecuador to New York state about 8 years ago and worked in carpentry. His past medical history, social history, and family history were unremarkable.
Vital signs were the following: temperature 32.2°C (rectal), pulse rate 43 per min, blood pressure 80/60 mmHg, respiratory rate 16 per min, and oxygen saturation 96% on 2-L nasal cannula. His hypotension responded to normal saline fluid hydration. Physical examination of the heart, lungs, abdomen, pupils, deep tendon reflexes, and muscle tone were within normal limits. Except for a sodium level of 132 mmol/L (averaging 125 mmol/L over the course of his stay), his complete blood count, electrolyte levels, urinalysis, urine toxicology, electrocardiogram, and chest radiograph showed no abnormalities. Computed tomography (CT) of the brain without contrast showed no evidence of acute large-vessel occlusive infarction or hemorrhage. Cerebrospinal fluid (CSF) analysis showed white blood cell count of 91 with 97% lymphocytes, protein level of 158 mg/dL, and glucose level of 20 mg/dL, with a negative acid-fast stain.
Further workup for encephalopathy included magnetic resonance imaging (MRI) of the brain without contrast. Acute infarctions were found, with involvement of the right caudate nucleus, anterior commissure, right superior cerebellar peduncle, and right cerebellar hemisphere with no evidence of hemorrhage (Figure 1). With high suspicion for TB, interferon gamma release assay (QuantiFERON®TB Gold; Qiagen) was performed and the result was positive. The patient was started on a 4-drug regimen for TB, which includes rifampin (10 mg/kg daily), pyrazin-amide (23 mg/kg daily), ethambutol (18 mg/kg daily), and isoniazid (5 mg/kg daily). CT scans of the neck, chest, abdomen, and pelvis showed enlarged lymph nodes in the axillary, common iliac, inguinal, and cervical regions (Figure 2A–2D). Confirmation for systemic TB infection was sought: a sub-centimeter right axillary lymph node was biopsied, with findings of caseous necrosis, acid-fast staining bacilli, and positive
One month after admission, the patient’s mental status showed moderate improvement. He was responsive to verbal commands but nuchal rigidity and confusion persisted. MRI of the brain without IV contrast at this time showed infarction in the basal ganglia, floor of the frontal lobes above the hypothalamus, and superior cerebellar vermis, (Figure 3). In addition, signs of communicating hydrocephalus on MRI were found (Figure 4). Following a family meeting, the patient was discharged home under the care of his family. Six months following discharge, he showed improved mental status.
Discussion
Early evidence for TB infection included lymphocytic pleocytosis and a positive interferon gamma release assay. A confirmatory diagnosis of TB was made based on positive culture, caseous necrosis, and acid-fast bacilli in the right axillary lymph node biopsy specimen. The imaging studies of the neck showed hypodense centers most consistent with scrofula and adenopathy (Figure 2D), while brain imaging showed infarctions (Figure 3), exudates at the floor of the brain (Figure 1B), and communicating hydrocephalus (Figure 4). These findings, combined with symptoms of headache, weight loss, and decreased consciousness, confirmed the diagnosis of TB meningitis with encephalitic features. Hyponatremia was thought to be due to syndrome of inappropriate antidiuretic hormone, which is seen in 45% of TB meningitis patients, and is generally associated with a poor clinical outcome.
Tuberculosis of the CNS, while uncommon [6], is classified on the basis of the following findings: cerebral abscess, tuberculomas [7,8], meningitis [7,10,11], and myelopathy [12–14]. Tuberculous meningitis, an important neurologic complication associated with HIV infection, has been well described in Africa [15] but reports are lacking in the USA.
CNS infarctions and communicating hydrocephalus are common findings in TB meningitis and are well described in the medical literature [16,17]. Hydrocephalus and infarctions are seen on CT scans in 12% and 28%, respectively, of adults with TB meningitis [18,19]. These infarctions are likely linked to compression and inflammation of large basal arteries secondary to histiocytic proliferation and adhesive meningitis found on tissue analysis [16]. Udani and Dastur (1970) [4] described tuberculous encephalopathy with and without meningitis presenting with diffuse features of brain involvement, including changes in level of consciousness, convulsions, involuntary movements, paralysis, and pyramidal/extrapyramidal and cerebellar signs. Pathology evidence were found for miliary, intracranial, intrathoracic and abdominal tuberculosis in 23%, 50%, 37%, and 27%, respectively [4]. While well described in the literature [16], tuberculous meningitis with encephalitic features is an uncommon presentation in patients in the USA.
Making a diagnosis of TB meningitis based solely on laboratory criteria can be difficult because co-infection with HIV makes the diagnosis challenging. Multiple studies have demonstrated increased incidence of TB meningitis in HIV-infected patients [9,20–22] because HIV infection is a strong risk factor for the progression of TB from asymptomatic to systemic infection [23], a risk which increases as CD4 counts decline [7]. Co-infection with HIV also modifies the lab findings because patients may present with acellular CSF and higher AFB loads [21]. However, Berenguer et al. [10] and Dube et al. [11] showed that TB meningitis clinical manifestations, CSF findings, and response to therapy were similar for those with and without HIV infection. A study of 53 adults suggested that HIV infection did not alter the clinical features of TB meningitis, although the cognitive dysfunction was more severe in patients co-infected with HIV [22]. The study found that HIV-infected patients did not develop tuberculoma and demonstrated less basal meningeal enhancement and hydrocephalus as compared with HIV-negative patients [22]. HIV infection is associated with higher rates of infarction and lower rates of hydrocephalus in patients with TB meningitis [5,24]. Interestingly, while our patient did not have tuberculomas, he had basal meningeal enhancement, infarctions, and hydrocephalus.
Paradoxical TB-immune reconstitution inflammatory syndrome (IRIS) has been described in the literature as an inflammatory response in the context of the recovering immune system in HIV patients. The clinical features of this condition include new or worsening meningitis, tuberculomas, and tuberculous brain accesses. Previous case reports and case series have shown the usefulness of prednisone for treatment of TB-IRIS [25]. The benefit of corticosteroid treatment for TB meningitis in HIV-infected patients is inconclusive, based on a recent review [26]. In the first prospective study of patients with HIV infection and TB meningitis [27], starting prednisone prior to HIV treatment did not significantly decrease the occurrence of TB-IRIS. Because of the relatively small sample size (34 patients), the present study may not have had sufficient statistical power to detect the effect of prednisone on the occurrence of IRIS [27]. While not shown to prevent TB-IRIS, prednisone was added to the regimen given the significant risk for TB-IRIS. The timing for starting highly active antiretroviral therapy should be balanced with the risk of developing opportunistic infections. In our patient, the HIV medications were started 5 days after the TB medications. This is considered early antiretroviral treatment (less than seven days after TB treatment) compared to delayed treatment (2 months after TB treatment) [25].
Conclusions
In patients presenting with constitutional symptoms and encephalopathic features, a high index of suspicion should be maintained for tuberculous meningitis and workup should include MRI screening, testing for HIV infection, and cerebral spinal fluid analysis. Regions in which TB is common, including the Caribbean, Pacific Islands, and South American countries, may also have higher prevalence of HIV infection, making the country of birth a significant part of the medical history. Treatment should be started based on a clinical picture consistent with tuberculous meningitis, which includes constitutional symptoms, foreign birth, lymphocytic pleocytosis, specific radiographic findings, and immunodeficiency. It is essential to treat co-infection with HIV and to address the possibility of immune reconstitution inflammatory syndrome. This case report should contribute toward the development of an organized approach to timely diagnosis and management of tuberculous meningitis.
References:
1.. , 2010, Switzerland, WHO Press
2.. , Trends in Tuberculosis, 2014 . Retrieved from .http://www.cdc.gov/tb/publications/factsheets/statistics/tbtrends.htm
3.. Braun MM, Byers RH, Heyward WL, Acquired immunodeficiency syndrome and extrapulmonary tuberculosis in the United States: Arch Intern Med, 1990; 150(9); 1913-16, pmid: 2393321
4.. Udani PK, Dastur DK, Tuberculous encephalopathy with and without meningitis. Clinical features and pathological correlations: J Neurol Sci, 1970; 10; 541-61, pmid: 5422557
5.. Vinnard C, Macgregor RR, Tuberculous meningitis in HIV-infected individuals: Curr HIV/AIDS Rep, 2009; 6(3); 139-45, pmid: 19589299
6.. Pons VG, Jacobs RA, Hollander H, Nonviral infections of the central nervous system in patients with acquired immunodeficiency syndrome: AIDS and the Nervous System, 1988; 263-83, New York, Raven Press
7.. Bishburg E, Sunderam G, Reichman LB, Central nervous system tuberculosis with the acquired immunodeficiency syndrome and its related complex: Ann Intern Med, 1986; 105(2); 210-13, pmid: 3729203
8.. Abós J, Graus F, Miró JM, Intracranial tuberculomas in patients with AIDS: AIDS, 1991; 5(4); 461-62, pmid: 2059389
9.. Fischl MA, Pitchenik AE, Spira TJ, Tuberculous brain abscess and toxoplasma encephalitis in a patient with the acquired immunodeficiency syndrome: JAMA, 1985; 253(23); 3428-30, pmid: 3999325
10.. Berenguer J, Moreno S, Laguna F, Tuberculous meningitis in patients infected with the human immunodeficiency virus: N Engl J Med, 1992; 326(10); 668-72, pmid: 1346547
11.. Dubé MP, Holtom PD, Larsen RA, Tuberculous meningitis in patients with and without human immunodeficiency virus infection: Am J Med, 1992; 93(5); 520-24, pmid: 1442854
12.. Doll DC, Yarbro JW, Phillips K, Mycobacterial spinal cord abscess with an ascending polyneuropathy: Ann Intern Med, 1987; 106(2); 333-34, pmid: 3800203
13.. Gallant JE, Mueller PS, McArthur JC, Intramedullary tuberculoma in a patient with HIV infection: AIDS, 1992; 6(8); 889-91, pmid: 1418794
14.. Woolsey RM, Chambers TJ, Chung HD, Mycobacterial meningomyelitis associated with human immunodeficiency virus infection: Arch Neurol, 1988; 45(6); 691-93, pmid: 3369978
15.. Lucas SB, Hounnou A, Peacock C, The mortality and pathology of HIV infection in a West African city: AIDS, 1993; 7(12); 1569-79, pmid: 7904450
16.. Dastur DK, Neurotuberculosis: Pathology of the Nervous System, 1972; 2412-22, New York, McGraw Hill
17.. Thwaites GE, Duc Bang N, Huy Dung N, The influence of HIV infection on clinical presentation, response to treatment, and outcome in adults with tuberculous meningitis: J Infect Dis, 2005; 192(12); 2134-41, pmid: 16288379
18.. Bhargava S, Gupta AK, Tandon PN, Tuberculous meningitis: A CT study: Br J Radiol, 1982; 55(651); 189-96, pmid: 7066619
19.. Tartaglione T, Di Lella GM, Cerase A, Diagnostic imaging of neurotuberculosis: Rays, 1998; 23(1); 164-80, pmid: 9673143
20.. Hakim JG, Gangaidzo IT, Heyderman RS, Impact of HIV infection on meningitis in Harare, Zimbabwe: A prospective study of 406 predominantly adult patients: AIDS, 2000; 14(10); 1401-7, pmid: 10930155
21.. Sánchez-Portocarrero J, Pérez-Cecilia E, Jiménez-Escrig A, Tuberculous meningitis. Clinical characteristics and comparison with cryptococcal meningitis in patients with human immunodeficiency virus infection: Arch Neurol, 1996; 53(7); 671-76, pmid: 8929175
22.. Katrak SM, Shembalkar PK, Bijwe SR, The clinical, radiological and pathological profile of tuberculous meningitis in patients with and without human immunodeficiency virus infection: J Neurol Sci, 2000; 181(1–2); 118-26, pmid: 11099721
23.. Braun MM, Byers RH, Heyward WL, Acquired immunodeficiency syndrome and extrapulmonary tuberculosis in the United States: Arch Intern Med, 1990; 150(9); 1913-16, pmid: 2393321
24.. Schuttle CM, Clincal, cerebrospinal fluid and pathological findings and outcomes in HIV-positive and HIV-negative patients with tuberculous meningitis: Infection, 2001; 29(4); 213-17, pmid: 11545483
25.. Marais S, Pepper DJ, Marais BJ, HIV-associated tuberculous meningitis – diagnostic and therapeutic challenges: Tuberculosis, 2010; 90(6); 367-74, pmid: 20880749
26.. Prasad K, Singh MB, Corticosteroids for managing tuberculous meningitis: Cochrane Database Syst Rev, 2008; 1; 1-36
27.. Marais S, Meintijes G, Pepper DJ, Frequency, severity, and prediction of tuberculous meningitis immune reconstitution inflammatory syndrome: Clin Infect Dis, 2013; 56(3); 450-60, pmid: 23097584
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.949976
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950290
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950607
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950985
Most Viewed Current Articles
07 Dec 2021 : Case report
17,691,734
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
06 Dec 2021 : Case report
164,491
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
21 Jun 2024 : Case report
113,090
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
59,175
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133






